More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated.

Corsten-Janssen, N; Saitta, S C; Hoefsloot, L H; McDonald-McGinn, D M; Driscoll, D A; Derks, R; Dickinson, K A; Kerstjens-Frederikse, W S; Emanuel, B S; Zackai, E H; van Ravenswaaij-Arts, C M A

Corsten-Janssen, N; Saitta, S C; Hoefsloot, L H; McDonald-McGinn, D M; Driscoll, D A; Derks, R; Dickinson, K A; Kerstjens-Frederikse, W S; Emanuel, B S; Zackai, E H; van Ravenswaaij-Arts, C M A.

Afiliación

Corsten-Janssen N; University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, The Netherlands.

Mol Syndromol ; 4(5): 235-45, 2013 Jun.

Article en En | MEDLINE | ID: mdl-23885230

Palabras clave

22q11.2 deletion syndrome; CHARGE syndrome; CHD7; TBX1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Mol Syndromol Año: 2013 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google